Noteworthily, FAP KO did not affect the weight, blood glucose level, IPGTT, and ITT of T2DM-induced HFpEF mice, indicating that its cardioprotective effects occur independently of glycemic control. The gene discussed is FAP; the disease is type 2 diabetes mellitus.